Literature DB >> 19103197

The changing paradigm of outflow resistance generation: towards synergistic models of the JCT and inner wall endothelium.

Darryl R Overby1, W Daniel Stamer, Mark Johnson.   

Abstract

Aqueous humor outflow resistance is the primary determinant of intraocular pressure (IOP), and increased outflow resistance is the basis for elevated IOP associated with glaucoma. Experimental evidence suggests that the bulk of outflow resistance is generated in the vicinity of the inner wall endothelium of Schlemm's canal, its basement membrane and the juxtacanalicular connective tissue (JCT). However, attempts to sort out the contribution of each of these tissues to total outflow resistance have not been successful. Conventional understanding of outflow resistance assumes that the resistance of each tissue strata (i.e., the inner wall endothelium, its basement membrane and JCT) in the outflow pathway adds in series to contribute to total outflow resistance generation. However, this perspective leads to a paradox where the apparent resistances of all tissues in the outflow pathway are much lower than the measured total resistance. To resolve this paradox, we explore synergistic models of outflow resistance generation where hydrodynamic interactions between different tissue strata lead to a total resistance that is greater than the sum of the individual tissue resistances. We closely examine the "funneling" hypothesis that has emerged as a leading synergistic model, and we review the basis of funneling, mechanical and biological requirements for funneling and evidence in support of this hypothesis. We also propose refinements to the funneling model and describe how funneling may relate to segmental variability of aqueous humor outflow patterns observed within the trabecular meshwork. Pressure gradients across the JCT and inner wall endothelium will generate mechanical loads that influence the morphology of these tissues. Because tissue morphology may in turn affect outflow resistance, there exists the potential for a two-way coupling or a "fluid-solid interaction" between outflow hydrodynamics and the mechanical behavior of the inner wall and JCT. Furthermore, the adhesions and tethers between the inner wall and JCT must be physically capable of supporting such loads. We examine the structure and mechanical strength of these adhesions, and provide evidence that these adhesions and tethers are unable to support the full load imposed by the bulk of outflow resistance generation unless a substantial fraction of outflow resistance is generated within the JCT, consistent with the funneling model. This indicates that these attachments between the inner wall and JCT have considerable physiological importance for outflow resistance regulation, by maintaining the proximity between these two tissues to facilitate funneling. Further study is greatly needed to better characterize these important interactions.

Entities:  

Mesh:

Year:  2008        PMID: 19103197      PMCID: PMC2744486          DOI: 10.1016/j.exer.2008.11.033

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  144 in total

1.  Effect of heparin II domain of fibronectin on aqueous outflow in cultured anterior segments of human eyes.

Authors:  Amy J Santas; Cindy Bahler; Jennifer A Peterson; Mark S Filla; Paul L Kaufman; Ernst R Tamm; Douglas H Johnson; Donna M Pesciotta Peters
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

2.  Hyaluronic acid and hyaluronidase in the aqueous humour and the angle of the anterior chamber.

Authors:  E H BARANY; A M WOODIN
Journal:  Acta Physiol Scand       Date:  1955

Review 3.  'What controls aqueous humour outflow resistance?'.

Authors:  Mark Johnson
Journal:  Exp Eye Res       Date:  2006-01-04       Impact factor: 3.467

4.  Effects of latrunculin-B on outflow facility and trabecular meshwork structure in human eyes.

Authors:  C Ross Ethier; A Thomas Read; Darren W-H Chan
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-05       Impact factor: 4.799

5.  Aqueous humor outflow: what do we know? Where will it lead us?

Authors:  Michael P Fautsch; Douglas H Johnson
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-10       Impact factor: 4.799

6.  Extracellular matrix gene alternative splicing by trabecular meshwork cells in response to mechanical stretching.

Authors:  Kate E Keller; Mary J Kelley; Ted S Acott
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-03       Impact factor: 4.799

Review 7.  Flow-mediated endothelial mechanotransduction.

Authors:  P F Davies
Journal:  Physiol Rev       Date:  1995-07       Impact factor: 37.312

Review 8.  Changes in aqueous humor dynamics with age and glaucoma.

Authors:  B'Ann True Gabelt; Paul L Kaufman
Journal:  Prog Retin Eye Res       Date:  2005-09       Impact factor: 21.198

9.  Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group.

Authors: 
Journal:  Am J Ophthalmol       Date:  1998-10       Impact factor: 5.258

10.  Distribution of syndecans 1-4 within the anterior segment of the human eye: expression of a variant syndecan-3 and matrix-associated syndecan-2.

Authors:  Mark S Filla; Guido David; Robert N Weinreb; Paul L Kaufman; Donna M Peters
Journal:  Exp Eye Res       Date:  2004-07       Impact factor: 3.467

View more
  112 in total

1.  The elastin fiber system between and adjacent to collector channels in the human juxtacanalicular tissue.

Authors:  Cheryl R Hann; Michael P Fautsch
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-05       Impact factor: 4.799

2.  Micro-invasive 360-degree suture trabeculotomy after successful canaloplasty – one year results.

Authors:  Anna-Maria Seuthe; Kai Januschowski; Peter Szurman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-01       Impact factor: 3.117

3.  A modified scleral dissection technique with suprachoroidal drainage for canaloplasty.

Authors:  Peter Szurman; Kai Januschowski; Karl Thomas Boden; Gesine Bettina Szurman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-12-14       Impact factor: 3.117

4.  Imaging the aqueous humor outflow pathway in human eyes by three-dimensional micro-computed tomography (3D micro-CT).

Authors:  Cheryl R Hann; Michael D Bentley; Andrew Vercnocke; Erik L Ritman; Michael P Fautsch
Journal:  Exp Eye Res       Date:  2010-12-25       Impact factor: 3.467

5.  Effects of Y27632 on aqueous humor outflow facility with changes in hydrodynamic pattern and morphology in human eyes.

Authors:  Chen-Yuan Charlie Yang; Ye Liu; Zhaozeng Lu; Ruiyi Ren; Haiyan Gong
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-28       Impact factor: 4.799

Review 6.  Focus on molecular events in the anterior chamber leading to glaucoma.

Authors:  Sergio Claudio Saccà; Alberto Izzotti
Journal:  Cell Mol Life Sci       Date:  2013-10-19       Impact factor: 9.261

7.  Intracameral Delivery of Layer-by-Layer Coated siRNA Nanoparticles for Glaucoma Therapy.

Authors:  Andrea E Dillinger; Michaela Guter; Franziska Froemel; Gregor R Weber; Kristin Perkumas; W Daniel Stamer; Andreas Ohlmann; Rudolf Fuchshofer; Miriam Breunig
Journal:  Small       Date:  2018-10-23       Impact factor: 13.281

8.  Secreted protein acidic and rich in cysteine (SPARC)-null mice exhibit more uniform outflow.

Authors:  Swarup S Swaminathan; Dong-Jin Oh; Min Hyung Kang; Ruiyi Ren; Rui Jin; Haiyan Gong; Douglas J Rhee
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-21       Impact factor: 4.799

Review 9.  Life under pressure: The role of ocular cribriform cells in preventing glaucoma.

Authors:  Jayter S Paula; Colm O'Brien; W Daniel Stamer
Journal:  Exp Eye Res       Date:  2016-08-25       Impact factor: 3.467

10.  Analyzing live cellularity in the human trabecular meshwork.

Authors:  Jose M Gonzalez; Sarah Hamm-Alvarez; James C H Tan
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-05       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.